Ser109

Site Information
GLAFAsNsLQRRKKG SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 36135877

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	lung cancer ( 3 ) , non-small cell lung cancer ( 3 ) , melanoma skin cancer ( 1 )
Relevant cell line - cell type - tissue:	HeLa (cervical) ( 2 ) , NCI-H1395 (pulmonary) ( 3 ) , NCI-H2030 (pulmonary) ( 3 ) , WM239A (melanocyte) ( 1 )

References
1	Stuart SA, et al. (2015) A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells. Mol Cell Proteomics 14, 1599-615 25850435 Curated Info
2	Sharma K, et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583-94 25159151 Curated Info
3	Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68 22617229 Curated Info